Successful drug development

Companies working in the drug development space are under increasing pressure to provide more innovative solutions for medications. Working with an end-to-end CDMO can help to reduce complexity and timelines, and ultimately ensure smoother progress to market.

CDMOs provide access to more technology and competence for dosage-form development locally as well as globally.

CDMOs provide access to more technology and competence for dosage-form development locally as well as globally. In addition to accessing technical capabilities and a global manufacturing network, pharma companies can also access years of development expertise. Outsourcing also gives organisations more internal resource to focus on core competencies. CDMOs that offer both development and commercial manufacturing services can help guide customers’ molecules from concept to market. 

In this article with Pharmaceutical Technology, Torkel Gren, Senior Director, Technology and Strategic Investments at Recipharm spoke about the importance of considering the end-user and the role of an outsourcing partner in successful drug development.

You can read more by clicking here.